Search
for

    Glossary 6-Mercaptopurine

    chemotherapy drug that inhibits cancer cell growth

    6-Mercaptopurine (6-MP) is a chemotherapy medication used primarily to treat certain types of cancer, such as acute lymphoblastic leukemia (ALL). It works by interfering with the growth of cancer cells, which are then destroyed by the body. 6-MP is also used in the treatment of some autoimmune diseases due to its immunosuppressive properties.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease Digestive and Liver Disease · 2012 · 68 citations
    2. The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents Cancer epidemiology · 2009 · 14 citations
    3. Synthesis and anticancer activity evaluation of Novel 6 mercaptopurine derivatives. Journals & Books Hosting (International Knowledge Sharing Platform) · 2015
    4. Methotrexate for induction of remission in ulcerative colitis Cochrane library · 2014 · 53 citations
    5. Methotrexate for maintenance of remission in ulcerative colitis Cochrane library · 2015 · 51 citations
    6. Psoriatic Skin Lesions Induced by Certolizumab Pegol Archives of Dermatology · 2010 · 21 citations
    7. Cutaneous Crohn's disease treated with infliximab and 4 years of follow up Australasian Journal of Dermatology · 2013 · 9 citations
    8. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases Frontiers in Pharmacology · 2021 · 21 citations
    9. Enteral nutrition for maintenance of remission in Crohn's disease Cochrane Database of Systematic Reviews · 2018 · 33 citations
    10. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease Journal of Gastroenterology · 2015 · 86 citations
    11. A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy Childhood Kidney Diseases · 2017
    12. Clinical Approach to the Patient With Alopecia Seminars in Cutaneous Medicine and Surgery · 2006 · 21 citations
    13. Chemotherapy-Induced Alopecia InTech eBooks · 2012 · 2 citations
    14. Budesonide for maintenance of remission in Crohn's disease Cochrane library · 2014 · 156 citations
    15. Mucocutaneous findings in hematolymphoid neoplasms: An observational study Indian Dermatology Online Journal · 2023 · 1 citations
    16. Mucocutaneous reactions to chemotherapy Journal of The American Academy of Dermatology · 1999 · 275 citations
    17. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations Pharmaceutics · 2024 · 32 citations
    18. A comprehensive review on invasomal carriers incorporating natural terpenes for augmented transdermal delivery Future Journal of Pharmaceutical Sciences · 2022 · 26 citations
    19. Data-driven strategies for drug repurposing: insights, recommendations, and case studies Briefings in Bioinformatics · 2025 · 2 citations
    20. LUPUS ERYTHEMATOSUS AND THE SKIN Elsevier eBooks · 2004 · 2 citations
    21. Introduction to Transplantology Elsevier eBooks · 2018 · 1 citations
    22. NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series Drug metabolism and drug interactions · 2020 · 10 citations
    23. Pellagra and anorexia nervosa: a case report Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · 2019 · 8 citations
    24. Thermographic Follow-up of a Mild Case of Herpes Zoster Archives of Dermatology · 2010 · 6 citations
    25. Telogen effl uvium as the fi rst symptom of Crohn's disease in a child 2014 · 1 citations
    26. Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity Indian Journal of Case Reports · 2025
    27. Cutaneous complications of chemotherapeutic agents Journal of The American Academy of Dermatology · 1983 · 172 citations
    28. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations
    29. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas British Journal of Dermatology · 2003 · 68 citations
    30. Hair Loss Pattern due to Chemotherapy-Induced Anagen Effluvium: A Cross-Sectional Observation Dermatology · 2007 · 53 citations